Serum urate: a biomarker or treatment target in pediatric hypertension?
1Department of Pediatrics, Division of Nephrology, School of Medicine, University of Alabama, Birmingham, Alabama 35233, USA.
Insights
Serum uric acid levels are linked to childhood essential hypertension, suggesting its use as a diagnostic biomarker. Further research is needed to confirm uric acid-lowering therapies for hypertension treatment.
Area of Science:
- Pediatric Nephrology
- Cardiovascular Research
- Metabolic Syndrome
Background:
- Essential hypertension in children is a growing concern.
- Hyperuricemia, or elevated serum uric acid, has been associated with essential hypertension in pediatric populations.
Purpose of the Study:
- To review the association between serum uric acid levels and essential hypertension in children.
- To explore the potential of serum uric acid as a diagnostic biomarker and therapeutic target for childhood hypertension.
Main Methods:
- Review of current scientific literature on hyperuricemia and childhood hypertension.
- Analysis of proposed mechanisms for uric acid-induced hypertension.
- Evaluation of evidence for uric acid-lowering agents and dietary interventions.
Main Results:
- A strong correlation exists between serum uric acid levels and essential hypertension in children, supporting its diagnostic utility.
- Uric acid-induced hypertension may have a reversible early phase, particularly relevant for new-onset cases.
- Preliminary studies indicate that uric acid-lowering agents like allopurinol and probenecid may reduce blood pressure in adolescents, but require further investigation.
- Dietary fructose intake is linked to hyperuricemia and hypertension, though the impact of fructose reduction on blood pressure needs confirmation.
Conclusions:
- Serum uric acid levels are a valuable biomarker for diagnosing essential hypertension in children.
- Additional research is necessary to validate the efficacy and safety of pharmacological and non-pharmacological methods for reducing serum uric acid as a hypertension therapy.
Purpose Of Review:
Studies have shown an association between hyperuricemia and essential hypertension in children, presenting the possibility for serum uric acid level to serve as a biomarker for diagnosis and potential treatment target.
Recent Findings:
The proposed mechanism of uric acid-induced hypertension is biphasic, with a reversible early phase, implying added significance for new-onset hypertension. Current evidence shows a strong correlation between uric acid level and essential hypertension, supporting its use in diagnosis. Small studies have shown that the use of uric acid-lowering agents allopurinol and probenecid can lower blood pressure in adolescents. These medications require further study in large populations and careful consideration of their side-effect profiles prior to clinical use as antihypertensive agents. Recent studies have also linked dietary fructose intake to hyperuricemia and hypertension, but the clinical effect of fructose reduction on blood pressure has not been confirmed.
Summary:
Current evidence supports use of serum uric acid level as a biomarker for diagnosis of essential hypertension in children. More research is needed to evaluate the utility of pharmacologic and nonpharmacologic means of serum uric acid reduction prior to clinical use as a therapy for hypertension.
Related Concept Videos
Serum Studies: Renal Function Tests
Hypertension III: Clinical Manifestations and Diagnostic Studies
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Nephrotic Syndrome II : Assessment and Medical Management
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Action of Diuretics
![Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F61682.jpg&w=3840&q=50)
